Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
- DOI
- 10.1200/po.20.00063
- Published
- 2020
- Container
- JCO precision oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/po.20.00063,
title = {Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.},
author = {Lee EK and Esselen KM and Kolin DL and Lee LJ and Matulonis UA and Konstantinopoulos PA},
year = {2020},
journal = {JCO precision oncology},
doi = {10.1200/po.20.00063},
url = {https://doi.org/10.1200/po.20.00063}
}RIS
TY - JOUR TI - Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type. AU - Lee EK AU - Esselen KM AU - Kolin DL AU - Lee LJ AU - Matulonis UA AU - Konstantinopoulos PA PY - 2020 JO - JCO precision oncology DO - 10.1200/po.20.00063 UR - https://doi.org/10.1200/po.20.00063 ER -
APA
EK, L., KM, E., DL, K., LJ, L., UA, M., & PA, K. (2020). Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.. JCO precision oncology. https://doi.org/10.1200/po.20.00063
Source records
- pubmed · retrieved 2026-09-25T06:32:23.228Z
- europe-pmc · retrieved 2026-09-25T06:32:23.215Z